The objective of our clinical intervention was to restore natural mechanisms of immune modulation by exploiting the ability of the mucosal route in inducing tolerization to a HSP-derived peptide, which we previously described as part of the pro-inflammatory mechanisms of RA pathogenesis[21]. Here, HSP90B2P is linked to rheumatoid arthritis.